Camptosar 20 mg/mL

Camptosar 20 mg/mL is an injectable solution containing irinotecan hydrochloride, used in cancer treatment protocols. This intravenous medication is supplied in single-dose vials for precise administration.

Camptosar 20 mg/mL is primarily used in the treatment of certain types of cancer. It is often included in chemotherapy regimens to target cancer cells and inhibit their growth. The medication works by interfering with the enzymes involved in DNA replication, which can help slow or stop the proliferation of cancer cells. Patients typically use this medication under the guidance of a healthcare provider as part of a broader treatment plan.

Common effects of Camptosar 20 mg/mL may include nausea, vomiting, diarrhea, and fatigue. Some patients may experience hair loss or changes in blood cell counts. These effects can vary widely among individuals and are generally managed with supportive care. It is important to discuss any persistent or severe side effects with a healthcare provider.

Camptosar 20 mg/mL should be handled with care, as it is a potent medication. It is essential to follow proper storage and disposal guidelines to ensure safety. Pregnant women or those planning to become pregnant should consult their healthcare provider before using this medication. Always use this medication under the supervision of a qualified healthcare professional.

Camptosar 20 mg/mL may interact with other medications, including those that affect liver enzymes or blood cell production. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy or safety of this medication. Always consult your healthcare provider before starting or stopping any medication.